ImmunoGen Competitors and Similar CompaniesClear all
Puma Biotechnology's competitors and similar companies include Immunomedics.
 Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. |  Immunomedics Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer. | |
Founding Date | Founding Date 2010 | Founding Date 1982 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Los Angeles, US HQ | Locations Morris Plains, US HQ |
Employees | Employees 27214% decrease | Employees 8914% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) $228.4m (FY, 2025) | Revenue (est.) $295k (FY, 2019) |
Cost of goods | Cost of goods $58.2m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $170.2m (FY, 2025) | Gross profit $295k (FY, 2019) |
Funding | ||
Total funding raised | Total funding raised $ 172m | Total funding raised $ 30m |
For sources of this data, please see the company profile
View Company Profiles
Immunomedics
HQ
Morris Plains, US
Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer.
View company